Quantcast
Channel: MassDevice
Browsing all 11515 articles
Browse latest View live

Image may be NSFW.
Clik here to view.

Lumendi wins FDA 510(k) for DiLumen endoscope positioning accessory

Medical device developer Lumendi said today it won FDA 510(k) clearance for its DiLumen endoscopic accessory. The Connecticut-based company’s DiLumen device is now indicated for use in positioning...

View Article



Image may be NSFW.
Clik here to view.

The history of clinical research

For research professionals involved in clinical trials, there is an immense responsibility of protecting human subjects, but history has taught us, unethical practice and disregard for the well-being...

View Article

Image may be NSFW.
Clik here to view.

Actelion, Sanofi in talks after J&J backs out of negotiations

Actelion (VTX:ATLN) and Sanofi (NYSE:SNY) are reportedly in talks to reach a takeover deal after Johnson & Johnson (NYSE:JNJ) said yesterday that it has closed negotiations with the Swiss biotech....

View Article

Image may be NSFW.
Clik here to view.

FDA approves first bioresorbable scaffold with autologous cells for cartilage...

Vericel Corp (NSDQ:VCEL) shares soared 56% today after the Cambridge, Mass.-based company said the FDA approved its bioresorbable scaffold for cartilage repair. The product, Maci, is the 1st...

View Article

Image may be NSFW.
Clik here to view.

Obama signs 21st Century Cures Act

President Obama yesterday signed the 21st Century Cures Act into law, the last step for the bill which has been 2 years in the making. Last week, the U.S. Senate voted 94-5 to pass the 21st Century...

View Article


Image may be NSFW.
Clik here to view.

Eli Lilly, Express Scripts offer insulin discount program

Eli Lilly (NYSE:LLY) said it is teaming up with pharmacy benefit manager Express Scripts (NSDQ:ESRX) to offer discounts on the US pharma giant’s insulin products for uninsured patients and people with...

View Article

Image may be NSFW.
Clik here to view.

Siemens invests $300m in Walpole, Mass facility

Siemens Healthineers (NYSE:SI) said today it is investing approximately $300 million over 4 years into its Walpole, Mass.-based laboratory diagnostics manufacturing and R&D facility. The Walpole...

View Article

Image may be NSFW.
Clik here to view.

Zimmer Biomet closes $1B senior debt offering

Zimmer Biomet (NYSE:ZBH) said today it closed its an offering of Euro-dominated senior notes, bringing in over $1 billion. The company brought in $530 million (EU €500 million) in principal amount of...

View Article


Image may be NSFW.
Clik here to view.

Bioventus picks up US Durolane rights from Galderma

Bioventus said today it inked a deal to pick up the U.S. rights for Durolane joint lubrication from Galderma for an undisclosed amount. Galderma’s Durolane is a single-injection, hyaluornic acid...

View Article


Image may be NSFW.
Clik here to view.

AARP report details increase in brand name drug prices

The AARP Public Policy Institute released a report today showing that 2015 was the 4th straight year of double-digit average annual increases for widely used brand name drugs. The nonprofit...

View Article

Image may be NSFW.
Clik here to view.

BioDelivery names Ginsberg as biz dev veep | Personnel Moves, Dec. 14, 2016

BioDelivery Sciences International (NSDQ:BDSI) said today that it named Peter Ginsberg as its VP of business development. Prior to joining the Raleigh, N.C.-based company, Ginsberg led business...

View Article

Image may be NSFW.
Clik here to view.

Zimmer-Biomet launches PrimaGen advanced bone allograft

Zimmer Biomet (NYSE:ZBH) said today it launched the PrimaGen advanced bone allograft designed as an allogeneic bone graft substitute for use in the repair, replacement, reconstruction or...

View Article

Image may be NSFW.
Clik here to view.

Researchers develop nanorockets that respond to changing temperatures

Researchers at Radboud University have developed nanorockets with temperature responsive “brakes”, enabling the carrier to stop in diseased tissues where temperatures are higher. The team’s work was...

View Article


Image may be NSFW.
Clik here to view.

MassDevice.com +5 | The top 5 medtech stories for December 14, 2016

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...

View Article

Image may be NSFW.
Clik here to view.

Clarius wins FDA 510(k) for wireless ultrasound device

Mobile ultrasound developer Clarius Mobile Health said today it won FDA 510(k) clearance for its C3 and L7 Clarius wireless ultrasound scanners. Clarius’ C3 multipurpose ultrasound scanner is designed...

View Article


Image may be NSFW.
Clik here to view.

GI Dynamics raises $1.1m in private placement

GI Dynamics (ASX:GID) said today it raised approximately $1.1 million (AU $1.5 million) and announced an upcoming security purchase plan looking to raise an additional $732,006 (AU $987,910). The...

View Article

Image may be NSFW.
Clik here to view.

Fresenius inks 5-year distro deal with Terumo to launch CATSmart in US

Fresenius (NYSE:FMS) business group Fresenius Kabi said today it inked a 5-year exclusive distribution deal with Terumo Corp. (TYO:4543) to launch Fresenius’ CATSmart autotransfusion system in the US....

View Article


Image may be NSFW.
Clik here to view.

J&J’s LifeScan wins FDA clearance for WellDoc integration of blood glucose data

Johnson & Johnson (NYSE:JNJ) subsidiary LifeScan said today it won FDA clearance for wireless integration of its OneTouch Verio Flex blood glucose monitoring system with WellDoc‘s FDA-approved...

View Article

Image may be NSFW.
Clik here to view.

Key elements of a viable post-market surveillance system

By Stewart Eisenhart, Emergo Group Although premarket registration and quality management system compliance garner a lot of attention from medical device companies eager to establish themselves in...

View Article

Image may be NSFW.
Clik here to view.

Hologic deals stake in Procleix blood-screening biz to Grifols for $1.9B

Hologic (NSDQ:HOLX) said yesterday that it agreed to deal its stake in the Procleix blood-screening business it runs with  Grifols (NSDQ:GRFS) for nearly $1.9 billion. Hologic, which makes the Procleix...

View Article
Browsing all 11515 articles
Browse latest View live




Latest Images